Aptamers Market Research Analysis:
Aptamers are oligonucleotides or peptide molecules that bind to target molecules of lipids, proteins or nucleic acids with high specificity. Aptamers are rapidly generated and applied during inhibition, specific detection and protein characterization. They can be used as detection reagents, pharmaceutical derivatives and functional proteomic levels with antibodies, small molecules and others. They can be selected from groups of oligonucleotides of random sequence to bind a broad range of biomedically relevant proteins with affinities and specificities comparable to the antibodies. Aptamers are versatile and economical and offer complementary or alternative solutions to antibodies. They have significant advantages over therapeutic proteins in terms of size, synthetic accessibility and modification by medical chemistry.
Aptamers Market Value Study:
Aptamers Market was worth USD 0.56 million in 2014 and is expected to reach approximately USD 5.25 million by 2023, with increasing a growth rate (CAGR) of 28.19% during the forecast period 2014 to 2023.
Aptamers Market Drivers and restraints:
Aptamer’s global market continues to experience positive growth as a result of increased research and development, and investments in pharmaceutical and biotechnology companies. Technological advances and the patented expiration of the systematic evolution of ligands through exponential enrichment technology (SELEX) will positively stimulate this market. With the advent of new technologies in the market, the cheaper cost and higher efficiency of the aptamer binding to larger molecules on the antibodies will help support the growth of the market. The increasing use of aptamers in drug discovery and treatment of diseases can have a positive impact on this market over a period of time. In addition to the above factors, it has been found that RNA aptamers have a great therapeutic and diagnostic value, with the recent approval of the first aptamer-based drug by the FDA and the addition of new drugs in clinical pipelines, leading to the growth of the market. However, ethical issues in using aptamers, stringent regulations and slow in reaching market place due to regulatory hurdles may hamper the growth of this market over forecast period.
Aptamers Market Geographical segmentation:
Geographically, North America and Europe will continue to be key regions for the Aptamers market. The European region should experience strong growth due to the presence of key players in the market. The Asia-Pacific region is expected to witness positive growth due to the increased opportunities for diagnosis and development of untapped pharmaceutical products in the market.
Aptamers Market major Players are mentioned in this report:
The main players in the global market are AM Biotechnologies, LLC, Aptagen, LLC, Aptamer Sciences, Inc., Aptamer Solutions Ltd, Aptus Biotech S.L., Base Pair Biotechnologies, Inc., NeoVentures Biotechnology, SomaLogic Inc., TriLink BioTechnologies, Inc., and Vivonics, Inc.
Research Cosmos is a provider of standard and customized Industry research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending Industry reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world
Company Name: Research Cosmos
Contact Person: Kevin Stewart
Email: Send Email
Address:4390 U.S 1, Suite 211
State: New Jersey
Country: United States